Alterations in the p16INK4a/cyclin D1/RB pathway in gastrointestinal tract endocrine tumors

American Journal of Clinical Pathology

Volumn 130, Issue 4, 2008, Pages 535-542

  Li, Anna Fen Yau ^a,b,e   Li, Alice Chia Heng ^c   Tsay, Shyh How ^a   Li, Wing Yin ^a   Liang, Wen Yih ^a   Chen, Jeou Yuan ^d  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c Webb Schools   (United States)

^d ACADEMIA SINICA   (Taiwan)

^e NONE   (Taiwan)

Author keywords

Carcinoid; Cyclin D1; Endocrine carcinoma; Gastrointestinal tract; p16INK4a; pRB; Retinoblastoma protein

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 2A; RETINOBLASTOMA PROTEIN;

ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; ENDOCRINE TUMOR; FEMALE; GASTROINTESTINAL TUMOR; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECTUM CARCINOMA; SMALL CELL CARCINOMA; BIOSYNTHESIS; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; NEUROENDOCRINE TUMOR; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; GASTROINTESTINAL NEOPLASMS; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; RETINOBLASTOMA PROTEIN;

EID: 54049096336     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/TLLVXK9HVA89CHPE     Document Type: Article

References (35)

1. Barakat MT, Meeran K, Bloom SR. Neuroendocrine tumours. Endocr Relat Cancer. 2004;11:1-18.
2. Leotlela PD, Jauch A, Holtgreve-Grez H, et al. Genetics of neuroendocrine and carcinoid tumours. Endocr Relat Cancer. 2003;10:437-450.
3. Lips CJ, Lentjes EG, Hoppener JW. The spectrum of carcinoid tumours and carcinoid syndromes. Ann Clin Biochem. 2003;40:612-627.
4. Dacic S, Finkelstein SD, Baksh FK, et al. Small-cell neuroendocrine carcinoma displays unique profiles of tumor-suppressor gene loss in relationship to the primary site of formation. Hum Pathol. 2002;33:927-932.
5. Pizzi S, Azzoni C, Bassi D, et al. Genetic alterations in poorly differentiated endocrine carcinomas of the gastrointestinal tract. Cancer. 2003;98:1273-1282.
6. Brenner B, Tang LH, Klimstra DS, et al. Small-cell carcinomas of the gastrointestinal tract: a review. J Clin Oncol. 2004;22:2730-2739.
7. Kusayanagi S, Konishi K, Miyasaka N, et al. Primary small cell carcinoma of the stomach. J Gastroenterol Hepatol. 2003;18:743-747.
8. Bernick PE, Klimstra DS, Shia J, et al. Neuroendocrine carcinomas of the colon and rectum. Dis Colon Rectum. 2004;47:163-169.
9. Van Gompel JJ, Sippel RS, Warner TF, et al. Gastrointestinal carcinoid tumors: factors that predict outcome. World J Surg. 2004;28:387-392.
10. Rorstad O. Prognostic indicators for carcinoid neuroendocrine tumors of the gastrointestinal tract. J Surg Oncol. 2005;89:151-160.
11. Hamilton S, Aaltonen LAH, eds. Pathology and Genetics of Tumours of the Digestive System. Lyon, France: IARC Press; 2000. World Health Organization Classification of Tumours.
12. Alexiev BA, Drachenberg CB, Papadimitriou JC. Endocrine tumors of the gastrointestinal tract and pancreas: grading, tumor size and proliferation index do not predict malignant behavior. Diagn Pathol. 2007;2:28. doi:10.1186/1746-1596-2-28.
13. Wistuba II, Gazdar AF, Minna JD. Molecular genetics of small cell lung carcinoma. Semin Oncol. 2001;28:3-13.
14. Beasley MB, Lantuejoul S, Abbondanzo S, et al. The p16/cyclin D1/Rb pathway in neuroendocrine tumors of the lung. Hum Pathol. 2003;34:136-142.
15. Igarashi T, Jiang SX, Kameya T, et al. Divergent cyclin B1 expression and Rb/p16/cyclin D1 pathway aberrations among pulmonary neuroendocrine tumors. Mod Pathol. 2004;17:1259-1267.
16. Johung K, Goodwin EC, DiMaio D. Human papillomavirus E7 repression in cervical carcinoma cells initiates a transcriptional cascade driven by the retinoblastoma family, resulting in senescence. J Virol. 2007;81:2102-2116.
17. Ma HB, Hu HT, Di ZL, et al. Association of cyclin D1, p16 and retinoblastoma protein expressions with prognosis and metastasis of gallbladder carcinoma. World J Gastroenterol. 2005;11:744-747.
18. Feakins RM, Nickols CD, Bidd H, et al. Abnormal expression of pRb, p16, and cyclin D1 in gastric adenocarcinoma and its lymph node metastases: relationship with pathological features and survival. Hum Pathol. 2003;34:1276-1282.
19. Kaye FJ. RB and cyclin dependent kinase pathways: defining a distinction between RB and p16 loss in lung cancer. Oncogene. 2002;21:6908-6914.
20. Yuan J, Knorr J, Altmannsberger M, et al. Expression of p16 and lack of pRB in primary small cell lung cancer. J Pathol. 1999;189:358-362.
21. Gugger M, Burckhardt E, Kappeler A, et al. Quantitative expansion of structural genomic alterations in the spectrum of neuroendocrine lung carcinomas. J Pathol. 2002;196:408-415.
22. Li AF-Y, Tsay S-H, Liang W-Y, et al. Clinical significance of p16INK4a and p53 overexpression in endocrine tumors of the gastrointestinal tract. Am J Clin Pathol. 2006;126:856-865.
23. Kotake Y, Cao R, Viatour P, et al. pRB family proteins are required for H3K27 trimethylation and Polycomb repression complexes binding to and silencing p16INK4alpha tumor suppressor gene. Genes Dev. 2007;21:49-54.
24. Travis WD, Brambilla E, Muller-Hermelink HK, et al, eds. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon, France: IARC Press; 2004. World Health Organization Classification of Tumours.
25. Li AF, Hsu CY, Li A, et al. A 35-year retrospective study of carcinoid tumors in Taiwan: differences in distribution with a high probability of associated second primary malignancies. Cancer. 2008;112:274-283.
26. Konishi T, Watanabe T, Kishimoto J, et al. Prognosis and risk factors of metastasis in colorectal carcinoids: results of a nationwide registry over 15 years. Gut. 2007;56:863-868.
27. Maggard MA, O'Connell JB, Ko CY. Updated population-based review of carcinoid tumors. Ann Surg. 2004;240:117-122.
28. Modlin IM, Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer. 1997;79:813-829.
29. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003;97:934-959.
30. Heinsohn S, Evermann U, Zur Stadt U, et al. Determination of the prognostic value of loss of heterozygosity at the retinoblastoma gene in osteosarcoma. Int J Oncol. 2007;30:1205-1214.
31. Wikenheiser-Brokamp KA. Retinoblastoma regulatory pathway in lung cancer. Curr Mol Med. 2006;6:783-793.
32. Esuvaranathan K, Chiong E, Thamboo TP, et al. Predictive value of p53 and pRb expression in superficial bladder cancer patients treated with BCG and interferon-alpha. Cancer. 2007;109:1097-1105.
33. Wang AY, Ahmad NA. Rectal carcinoids. Curr Opin Gastroenterol. 2006;22:529-535.
34. Robertson RG, Geiger WJ, Davis NB. Carcinoid tumors. Am Fam Physician. 2006;74:429-434.
35. Kawahara M, Kammori M, Kanauchi H, et al. Immunohistochemical prognostic indicators of gastrointestinal carcinoid tumours. Eur J Surg Oncol. 2002;28:140-146.